TRIDENT LIFELINE
Back to Income Statement
|
TRIDENT LIFELINE Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Consolidated Net Profit | ₹6.34 Cr | ₹6.02 Cr | ₹3.95 Cr |
What is the latest Consolidated Net Profit of TRIDENT LIFELINE ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹6.34 Cr |
Mar2023 | ₹6.02 Cr |
Mar2022 | ₹3.95 Cr |
How is Consolidated Net Profit of TRIDENT LIFELINE Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹6.34 Cr | 5.47 | |
Mar2023 | ₹6.02 Cr | 52.36 | |
Mar2022 | ₹3.95 Cr | - |
Compare Consolidated Net Profit of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹319.7 Cr | -10.2% | 4.1% | 79.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | -10.2% |
4.1% |
79.4% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses